CRT 2026
Coronary
Florim Cuculi, MD
Head of Cardiology
Heart Center Lucerne, Luzern, Switzerland
Disclosure(s): No financial relationships to disclose
Lorenzo Azzalini, MD, PhD, MSc
Interventional Cardiologist
University of Washington
Seattle, Washington, United States
Disclosure(s): Dr. Azzalini received consulting fees from Teleflex, Abiomed, GE Healthcare, Reflow Medical, Shockwave Medical, Abbott, Boston Scientific, XyloCor Therapeutics, HeartFlow, and Cardiovascular Systems, Inc.; and owns equity in Reflow Medical.: Consulting Fees (e.g., advisory boards) (Ongoing)
Rhian E. Davies, DO MS
Interventional Cardiology
WellSpan York Hospital
Annville, Pennsylvania, United States
Disclosure(s): Terumo: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Emmanouil S. Brilakis, MD, PhD
Director, Center for Advanced Coronary Interventions
Minneapolis Heart Institute
Minneapolis, Minnesota, United States
Disclosure(s): SIS Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Terumo Corporation: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Darshan Doshi, MD, MS
Interventional Cardiologist
Massachusetts General Hospital / Harvard Medical School, Massachusetts, United States
Disclosure information not submitted.
Shigeru Saito, MD, FACC, FSCAI
Director, Heart Center
Shonan Kamakura General Hospital
Kamakura, Kanagawa, Japan
Disclosure(s): Elixir Medical: Consulting Fees (e.g., advisory boards) (Ongoing)
Alpesh Shah, MD
Director of Coronary Interventions, Associate Professor
Houston Methodist Hospital
Houston, Texas, United States
Disclosure(s): No financial relationships to disclose
Gerald S. Werner, MD, PhD, FSCAI
Senior Consultant CTO
University Heart Center Frankfurt/Main
Frankfurt am Main, Hessen, Germany
Disclosure information not submitted.
Masahisa Yamane, MD
Senior Advisor
Saitama Sekishinkai Hospital
Tokyo, Tokyo, Japan
Disclosure(s): Asahi Intecc, Japan: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)